Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- ChecktodayChange DetectedAdded State of Vienna as a location and refined the Vienna address to Vienna, State of Vienna, Austria, 1160. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check7 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the related 'MedlinePlus Genetics' topic from the page's related topics.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics in the related topics section.SummaryDifference0.0%

- Check22 days agoChange DetectedBeijing, China (Beijing Municipality) with Peking Union Medical College Hospital was added; Genova, Italy added IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM). Removed entries include Beijing Peking Union Medical College Hospital and Genoa-related sites such as Ospedale San Martino and Liguria, with the total study locations changing to 238.SummaryDifference0.5%

- Check29 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics'. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.